Possible scenario
Mostly Advisory Rollout
42% Chance
The task force functions mainly as a coordinating body between the White House, HHS, NIH, FDA, and CDC. It produces reports, listening sessions, and grant-review recommendations without immediately changing reimbursement, drug approvals, or clinical guidance.
Secondary impacts
- Healthcare +0.1%
Tickers
- MYGN+0.5%
- MRNA-0.4%
- PFE-0.1%
- MRK-0.1%
Portfolio impact
S&P 500+0.0%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.